Topical and transdermal lipid-polymer hybrid nanoparticles (LPN): an integration in advancing dermatological treatments
Authors:
Open Access
- 13 August 2025
- journal article
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 15 (11) , 4277-4313
Abstract
Lipid–polymer hybrid nanoparticles (LPN) are an integration or “collaboration” between the two distinct drug delivery platforms of lipid and polymeric carriers. The idea centres on coining the advantages of both materials while attempting to overcome the limitations inherent to each component, thus improving biocompatibility, drug loading, stability, size uniformity, and controlled release properties. Since their emergence over two decades ago, LPN have attracted growing interest in various therapeutic areas such as cancer, neurological disorders, osteoarthritis, and COVID-19 viral infections. Their structural diversity has expanded from the classical polymeric core-lipid shell to its inverse structure of lipid core-polymeric shell and homogeneous lipid-polymer blends, producing nine types of LPN under these structural classes. Correspondingly, preparation strategies have evolved from two-step methods to integrated one-step method of nanoprecipitation, single-emulsification-solvent evaporation, and double-emulsification-solvent evaporation in the early 2010s. More recently, novel methods such as self-assembly, modified ionic gelation, modified ethanolic injection, film rehydration, and hot-melt emulsification have been introduced, with hot-melt emulsification showing particular promise for scalability. In this context, the present review proactively introduces an updated structural classification and proposes a revision of existing formulation strategies by expanding the one-step and two-step framework to incorporate emerging methods tailored for dermatological applications. While LPN are often portrayed as a better version of lipid and polymeric-based nanoparticles, their practical applicability in dermatological treatments remains an open question. Therefore, this review evaluates LPN’s clinical and translational potential in dermatology applications such as, wounds, skin infections, dermatitis, psoriasis, skin cancer, pain management, and cosmetic applications. Graphical abstract A collaborative fusion of lipid and polymer to create Lipid-Polymer Hybrid nanoparticles for advanced dermatological treatmentsKeywords
Funding Information
- Monash University
This publication has 137 references indexed in Scilit:
- Targeted lipid-coated nanoparticles: Delivery of tumor necrosis factor-functionalized particles to tumor cellsJournal of Controlled Release, 2009
- Lipid nanoparticles as vehicles for topical psoralen delivery: Solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)European Journal of Pharmaceutics and Biopharmaceutics, 2008
- Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery PlatformACS Nano, 2008
- Cosmetic features and applications of lipid nanoparticles (SLN®, NLC®)International Journal of Cosmetic Science, 2008
- Polymer-Caged Lipsomes: A pH-Responsive Delivery System with High StabilityJournal of the American Chemical Society, 2007
- Development of a Respirable, Sustained Release Microcarrier for 5-Fluorouracil I: In Vitro Assessment of Liposomes, Microspheres, and Lipid Coated NanoparticlesJournal of Pharmaceutical Sciences, 2006
- Transfollicular drug delivery—Is it a reality?International Journal of Pharmaceutics, 2005
- Physicochemical and Interfacial Investigation of Lipid/Polymer Particle AssembliesLangmuir, 2005
- Evaluation of Effect of Charge and Lipid Coating on Ability of 60-nm Nanoparticles to Cross an In Vitro Model of the Blood-Brain BarrierThe Journal of Pharmacology and Experimental Therapeutics, 1999
- Acyclovir Bioavailability in Human SkinJournal of Investigative Dermatology, 1992